Healionics Revenue and Competitors

Seattle, WA USA

Location

$16.7M

Total Funding

Estimated Revenue & Valuation

  • Healionics's estimated annual revenue is currently $3M per year.(i)
  • Healionics's estimated revenue per employee is $301,200
  • Healionics's total funding is $16.7M.

Employee Data

  • Healionics has 10 Employees.(i)
  • Healionics grew their employee count by 25% last year.

Healionics's People

NameTitleEmail/Phone
1
CEO & ChairmanReveal Email/Phone
2
Director & Chief Technology OfficerReveal Email/Phone
3
Quality and Regulatory EngineerReveal Email/Phone
4
Lead R&D and Quality EngineerReveal Email/Phone
5
President and COOReveal Email/Phone
6
clinical trial medical AssistantReveal Email/Phone
7
Biomaterials Manufacturing Engineer IReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.9M39117%$14.9MN/A
#2
$44.9M143-30%$211.3MN/A
#3
$54M17211%$35.5MN/A
#4
$4.3M17-19%N/AN/A
#5
$18.3M73N/AN/AN/A
#6
$8.3M336%N/AN/A
#7
$81.1M32317%N/AN/A
#8
$7M28-12%N/AN/A
#9
$204.8M8163%N/AN/A
#10
$6.3M5025%$27.5MN/A
Add Company

What Is Healionics?

Healionics Corporation provides biomaterial solutions to research institutions and medical device manufacturers seeking to enhance the biocompatibility and performance of current and next generation devices. Healionics has exclusive license to breakthrough technologies in biocompatibility created by University of Washington Engineered Biomaterials group (UWEB) over a 9-year period with $30M in funding as a US National Science Foundation Engineering Research Center (NSF ERC). Healionics' initial focus is to supply the innovative STAR material to qualified partners and customers.

keywords:Medical Devices

$16.7M

Total Funding

10

Number of Employees

$3M

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Healionics News

2021-05-13 - Healionics raises $4.7M equity round to support commercialization of STARgraft vascular graft

SEATTLE, May 13, 2021 /PRNewswire/ -- Healionics Corporation, a private medical device company, announced today the completion of a $4.7M equity financing round led by Keiretsu Capital. The company also announced the conversion to equity of $5.2M in previously outstanding notes and interest. ...

2021-05-13 - Healionics raises $4.7M to commercialize artificial blood vessel tech

Healionics’ STARgraft vascular graft acts as an artificial blood vessel for dialysis patients. (Healionics Photo) New funding: Seattle-based medical technology company Healionics raised a $4.7 million round led by Keiretsu Capital to help commercialize its artificial blood vessel called STARgra ...

2021-05-13 - Healionics Closes $4.7M Equity Financing

Healionics Corporation, a Seattle, WA-based private medical device company, closed a $4.7M equity financing. The round was led by Keiretsu Capital. The company also announced the conversion to equity of $5.2M in previously outstanding notes and interest. Led by Mike Connolly, Chief Executive O ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M100%N/A
#2
$1.5M10-89%N/A
#3
$17.5M10-33%$221M
#4
$0.9M10N/AN/A
#5
$0.9M10N/AN/A